VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 295 filers reported holding VALEANT PHARMACEUTICALS INTL in Q2 2018. The put-call ratio across all filers is 2.21 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $483,000 | +40.4% | 20,794 | -3.7% | 0.26% | +18.6% |
| Q1 2018 | $344,000 | +0.9% | 21,594 | +31.7% | 0.22% | -6.8% |
| Q4 2017 | $341,000 | +100.6% | 16,394 | +37.8% | 0.24% | +82.3% |
| Q3 2017 | $170,000 | -17.5% | 11,894 | 0.0% | 0.13% | -29.0% |
| Q2 2017 | $206,000 | +50.4% | 11,894 | -4.0% | 0.18% | +84.8% |
| Q1 2017 | $137,000 | -23.9% | 12,394 | 0.0% | 0.10% | -19.5% |
| Q4 2016 | $180,000 | – | 12,394 | – | 0.12% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Brave Warrior Advisors | 6,050,442 | $763,082,000 | 30.78% |
| LeVasseur Capital Partners LLC | 190,404 | $24,014,000 | 29.50% |
| FARLEY CAPITAL L.P. | 333,081 | $42,008,000 | 27.09% |
| Ruane, Cunniff & Goldfarb | 34,298,384 | $4,325,712,000 | 23.07% |
| ValueAct Holdings | 18,923,877 | $2,386,679,000 | 17.64% |
| Tesuji Partners | 1,368,040 | $172,537,000 | 17.22% |
| Brahman Capital Corp. | 3,902,877 | $492,231,000 | 13.63% |
| Arrow Capital Management, LLC | 197,500 | $24,909,000 | 13.60% |
| Hound Partners | 2,851,175 | $359,590,000 | 13.45% |
| Ratan Capital Management LP | 731,960 | $92,315,000 | 13.09% |